1. Home
  2. AUR vs KRYS Comparison

AUR vs KRYS Comparison

Compare AUR & KRYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Aurora Innovation Inc.

AUR

Aurora Innovation Inc.

HOLD

Current Price

$6.59

Market Cap

8.5B

Sector

Technology

ML Signal

HOLD

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$286.24

Market Cap

7.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AUR
KRYS
Founded
2017
2015
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
8.5B
7.8B
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
AUR
KRYS
Price
$6.59
$286.24
Analyst Decision
Buy
Strong Buy
Analyst Count
4
11
Target Price
$9.43
$297.60
AVG Volume (30 Days)
20.1M
215.1K
Earning Date
05-06-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
128.00
EPS
N/A
1.83
Revenue
N/A
$389,130,000.00
Revenue This Year
$407.30
$38.74
Revenue Next Year
$1,134.58
$32.53
P/E Ratio
N/A
$152.60
Revenue Growth
N/A
33.94
52 Week Low
$3.60
$123.03
52 Week High
$8.19
$298.30

Technical Indicators

Market Signals
Indicator
AUR
KRYS
Relative Strength Index (RSI) 78.58 62.13
Support Level $5.20 $254.53
Resistance Level N/A $293.60
Average True Range (ATR) 0.36 11.85
MACD 0.17 0.96
Stochastic Oscillator 94.81 62.50

Price Performance

Historical Comparison
AUR
KRYS

About AUR Aurora Innovation Inc.

Aurora Innovation Inc delivers self-driving technology safely, quickly, and broadly. The Aurora Driver is a self-driving system designed to operate multiple vehicle types, from freight-hauling trucks to ride-hailing passenger vehicles. It underpins Aurora Horizon and Aurora Connect, its driver-as-a-service products for trucking and ride-hailing. The Company is developing the Aurora Driver, a scalable suite of self-driving hardware, software, and data services designed as a platform to adapt and interoperate among vehicle types and applications.

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

Share on Social Networks: